Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Annual Report and Accounts 2012/13 - Royal Devon & Exeter Hospital
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
4. Our Governance<br />
<strong>Royal</strong> <strong>Devon</strong> <strong>and</strong> <strong>Exeter</strong> NHS Foundation Trust<br />
<strong>Annual</strong> <strong>Report</strong> <strong>and</strong> <strong>Accounts</strong> <strong>2012</strong>/<strong>13</strong><br />
81<br />
of its transformation programme.<br />
The Senior Management Review has<br />
focused on assessing whether the<br />
senior management structure was:<br />
1) enabling as efficient delivery as<br />
possible of current patient services<br />
2) capable of delivering the future<br />
strategy. The scope of the review<br />
included some B<strong>and</strong> 7 roles up to,<br />
<strong>and</strong> including, the Executive Team.<br />
The EDRC welcomed the SMR because<br />
the Committee was keen to ensure<br />
that the senior leadership team had<br />
the right capacity <strong>and</strong> capability<br />
to maintain its 'business as usual'<br />
performance but also transform<br />
the way the organisation meets its<br />
objectives, so that it is able to deliver<br />
good quality services that meet the<br />
needs of patients in a financially<br />
sustainable way. The EDRC have been<br />
clear that achieving these goals during<br />
a time of austerity was mission-critical<br />
but, given the volume <strong>and</strong> complexity<br />
of the work underway, represented<br />
perhaps the biggest challenge that<br />
had faced the Trust in a generation. The<br />
Committee engaged in developing the<br />
senior management review in relation to:<br />
• Ensuring that the revised portfolios<br />
of the Executive Director team was<br />
appropriate <strong>and</strong> fit for purpose<br />
• Ensuring that, in the design of the<br />
SMR, there was sufficient capacity<br />
<strong>and</strong> capability in the rung below<br />
the Executive Directors<br />
• To either make any changes to the<br />
structure cost-neutral or to reduce<br />
expenditure.<br />
The Committee agreed the reshaped<br />
portfolios of the Executive team during<br />
the year. The main changes were:<br />
• The reduction in the number of<br />
Executive Directors from five to<br />
four posts<br />
• The establishment of a<br />
new Executive Director of<br />
Transformation <strong>and</strong> Organisational<br />
Development to drive the new<br />
ways of working both within the<br />
Trust <strong>and</strong> beyond its four walls, to<br />
ensure that the services offered<br />
by the Trust are delivered to a<br />
good quality, meet the needs of<br />
patients <strong>and</strong> are undertaken in a<br />
financially sustainable way. This<br />
new role includes some functional<br />
areas linked to the transformation<br />
agenda such as Organisational<br />
Development, Human Resources<br />
<strong>and</strong> Communications <strong>and</strong><br />
Engagement. This post was<br />
advertised during the year <strong>and</strong> the<br />
post will be taken up during April<br />
20<strong>13</strong><br />
• Bringing together a new<br />
role encompassing nursing,<br />
performance <strong>and</strong> operations,<br />
patient safety, quality <strong>and</strong><br />
engagement, <strong>and</strong> governance in<br />
a Chief Nurse/Executive Director<br />
of Service Delivery. This role was<br />
taken up by Em Wilkinson-Brice<br />
from the 1st December <strong>2012</strong>.<br />
The Committee considered the<br />
appropriate remuneration for this<br />
new role based on relativities with<br />
other ED portfolios. On the basis<br />
of this comparison, the Committee<br />
took a view about the appropriate<br />
level of compensation <strong>and</strong> this is<br />
reflected in the accounts.<br />
• The establishment of a single,<br />
full-time Medical Director is a<br />
move away from the existing<br />
arrangements, in which the Trust<br />
has a single post filled through<br />
a job share. This was felt by the<br />
Committee to be an important<br />
change in ensuring that greater<br />
capacity could be applied to the<br />
leadership necessary for the clinical<br />
staff in the Trust. This post was<br />
advertised <strong>and</strong> recruited during the<br />
year <strong>and</strong> the new post-holder will<br />
take up the position in the next<br />
financial year.<br />
In addition to the changes made at<br />
the Executive Director level, the<br />
Committee also helped develop<br />
proposals for the tier below Executive<br />
Directors. To support the new Chief<br />
Nurse/Executive Director of Service<br />
Delivery the supporting sub-structure<br />
has been re-organised <strong>and</strong> an<br />
Operations Director role has been<br />
established. Mr Peter Adey took up this<br />
role in March 20<strong>13</strong>.<br />
The clinical <strong>and</strong> operational structure<br />
within the Trust has also been reviewed<br />
<strong>and</strong> proposals are currently subject<br />
to staff consultation. Within the<br />
proposal structure the focus has been<br />
on streamlining lines of reporting<br />
<strong>and</strong> enhancing engagement in the<br />
leadership of the Trust. The structure<br />
will establish three new clinical<br />
divisions, replacing the current five,<br />
each headed by a Divisional Director.<br />
The remuneration for the new<br />
Divisional Director roles will be set<br />
by the EDRC. The establishment of a<br />
re-organised supporting management<br />
tier was to extend the number of<br />
posts that fall within the remit of the<br />
Committee.